Argatroban for the Treatment of Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials
Open Access
- 18 April 2026
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 270, 120-123
Abstract
No abstract availableFunding Information
- McGill University
- Santé
This publication has 8 references indexed in Scilit:
- Adjunctive Intravenous Argatroban or Eptifibatide for Ischemic StrokeNew England Journal of Medicine, 2024
- Argatroban in Patients With Acute Ischemic Stroke With Early Neurological DeteriorationJAMA Neurology, 2024
- Efficacy and safety of argatroban in the management of acute ischemic stroke: A systematic literature review and meta-analysisClinical Neurology and Neurosurgery, 2023
- Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic StrokeJAMA, 2023
- Japan Stroke Society Guideline 2021 for the Treatment of StrokeInternational Journal of Stroke, 2022
- Access to Mechanical Thrombectomy for Ischemic Stroke in the United StatesStroke, 2021
- Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke AssociationStroke, 2019
- Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)Stroke, 2017